Possible involvement of signal transducers and activators of transcription 3 system on depression in the model mice brain

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 4, 2010, Pages 636-640

  Mingmalairak, Salin ^a   Tohda, Michihisa ^a   Murakami, Yukihisa ^a   Matsumoto, Kinzo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Depressive disorder; Gene expression; Learned helplessness; Signal transducer and activator of transcription 3 inter acting protein

Indexed keywords

BINDING PROTEIN; MESSENGER RNA; STAT3 INTERACTING PROTEIN 1; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR GENETICS; CONTROLLED STUDY; DEPRESSION; DOWN REGULATION; FRONTAL CORTEX; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION PROFILING; HIPPOCAMPUS; LEARNED HELPLESSNESS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; UPREGULATION;

ANIMALS; BRAIN; DEPRESSION; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENES; GENETIC PREDISPOSITION TO DISEASE; HELPLESSNESS, LEARNED; MALE; MICE; MICE, INBRED ICR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTIONAL ACTIVATION;

EID: 77950909228     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.636     Document Type: Article

References (37)

1. Monroe S. M., Reid M. W., Psychol. Sci., 19, 947-956 (2008).
2. Nestler E. J., Barrot M., DiLeone R. J., Eisch A. J., Gold S. J., Monteggia L. M., Neuron, 34, 13-25 (2002).
3. Kendler K. S., Thornton L. M., Gardner C. O., Am. J. Psychiatry, 157, 1243-1251 (2000).
4. Leverich G. S., Perez S., Luckenbaugh D. A., Post R. M., Clin. Neurosci. Res., 2, 161-170 (2002).
5. Post R. M., Am. J. Psychiatry, 149, 999-1010 (1992).
6. Chourbaji S., Zacher C., Sanchis-Segura C., Dormann C., Vollmayr B., Gass P., Brain Res. Protoc., 16, 70-78 (2005).
7. Takamori K., Yoshida S., Okuyama S., Pharmacology, 63, 147-153 (2001).
8. Willner P., Adv. Biochem. Psychopharmacol., 49, 19-41 (1995).
9. Kram M. L., Kramer G. L., Steciuk M., Ronan P. J., Petty F., Neuroscience, 38, 193-198 (2000).
10. Vollmayr B., Simonis C., Weber S., Gass P., Henn F., Biol. Psychiatry, 54, 1035-1040 (2003).
11. Maier S. F., Seligman M. E., J. Exp. Psychol. Gen., 105, 3-46 (1976).
12. Tohda M., Hayashi H., Sukma M., Tanaka K., Neurosci. Res., 62, 1-8 (2008).
13. Tohda M., Mingmalairak S., Murakami Y., Matsumoto K., Biol. Pharm. Bull., 33, 53-57 (2010).
14. Bunney W. E., Bunney B. G., Vawter M. P., Tomita H., Li J., Evans S. J., Choudary P. V., Myers R. M., Jones E. G., Watson S. J., Akil H., Am. J. Psychiatry, 160, 657-666 (2003).
15. Iwamoto K., Kato T., Neuroscientist, 12, 349-361 (2006).
16. Mirnics K., Middleton F. A., Lewis D. A., Levitt, P., Trends Neurosci., 24, 479-486 (2001).
17. Orsetti M., Di Brisco F., Canonico P. L., Genazzani A. A., Ghi P., Eur. J. Neurosci., 27, 2156-2164 (2008).
18. Joo Y., Choi K. M., Lee Y. H., Kim G., Lee D. H., Roh G. S., Kang S. S., Cho G. J., Choi W. S., Kim H. J., Neurosci. Lett., 461, 121-125 (2009).
19. Uriguen L., Artera D., Diez-Alarcia R., Ferrer-Alcon M., Diaz A., Pazos A., Meana J. J., Genes Brain Behav., 7, 649-658 (2008).
20. Orsetti M., Brisco F. D., Rinaldi M., Dallorto D., Ghi P., Pharmacogenet. Genomics, 19, 600-612 (2009).
21. Czeh B., Lucassen P. J., Eur. Arch. Psychiatry Clin. Neurosci., 257, 250-260 (2007).
22. Chen F., Madsen T. M., Wegener G., Nyengaard J. R., Hippocampus, DOI 10.1002/hipo.20718 (2009).
23. Leonard B. E., Myint, A., Hum. Psychopharmacol. Clin. Exp., 24, 165-175 (2009).
24. Collum R. G., Brutsaert S., Lee G., Schindler C., Proc. Natl. Acad. Sci. U.S.A., 97, 10120-10125 (2000).
25. Dziennis S., Alkayed N. J., Rev. Neurosci., 19, 341-361 (2008).
26. O'Brien S. M., Scott L. V., Dinan T. G., Hum. Psychopharmacol., 19, 397-403 (2004).
27. Penninx B. W., Kritchevsky S. B., Yaffe K., Newman A. B., Simonsick E. M., Rubin S., Biol. Psychiatry, 54, 566-572 (2003).
28. Bremner J. D., Narayan M., Anderson E. R., Staib L. H., Miller H. L., Charney D. S., Am. J. Psychiatry, 157, 115-118 (2000).
29. Sheline Y. I., Wang P. W., Gado M. H., Csernansky J. G., Vannier M. W., Proc. Natl. Acad. Sci. U.S.A., 93, 3908-3913 (1996).
30. Qin H., Roberts K. L., Niyongere S. A., Cong Y., Elson C. O., Benveniste E. N., J. Immunol., 179, 5966-5976 (2007).
31. Starr R., Willson T. A., Viney E. M., Murray L. J., Rayner J. R., Jenkins B. J., Gonda T. J., Alexander W. S., Metcalf D., Nicola N. A., Hilton D. J., Nature (London), 387, 917-921 (1997).
32. Yoshimura A., Naka T., Kubo M., Nat. Rev. Immunol., 7, 454-465 (2007).
33. Carmichael S. T., Curr. Opin. Neurol., 16, 699-704 (2003).
34. Raghavendra Rao V. L., Dhodda V. K., Song G., Bowen K. K., Dempsey R. J., J. Neurosci. Res., 71, 208-219 (2003).
35. Tangye S. G., Cook M. C., Fulcher D. A., J. Immunol., 182, 21-28 (2009).
36. Berger J., Bird A., Biochem. Soc. Trans., 33, 1537-1540 (2005).
37. Maes M., Yirmyia R., Noraberg J., Brene S., Hibbeln J., Perini G., Kubera M., Bob P., Lerer B., Maj M., Metab. Brain Dis., 24, 27-53 (2009).